Literature DB >> 20645661

Diabetes disease management in Medicare Advantage reduces hospitalizations and costs.

James L Rosenzweig1, Michael S Taitel, Gordon K Norman, Tim J Moore, Wendy Turenne, Pei Tang.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a telephonic diabetes disease management intervention in a Medicare Advantage population with comorbid diabetes and coronary artery disease (CAD). STUDY
DESIGN: Prospective unequal randomization design of 526 members from a Medicare Advantage segment of one region of a large national health plan from May 2005 through April 2007.
METHODS: High-risk and high-cost patients with diabetes and CAD who were enrolled in telephonic diabetes disease management were compared with a randomly selected comparison group receiving usual care. Wilcoxon signed-rank tests were used to compare the groups on all-cause hospital admissions, diabetes-related hospital admissions, all-cause and diabetes-related emergency department (ED) visits, and all-cause medical costs. Changes in self-reported clinical outcomes also were measured in the intervention group.
RESULTS: Patients receiving telephonic diabetes disease management had significantly decreased all-cause hospital admissions and diabetes-related hospital admissions (P <.05). The intervention group had decreased all-cause and diabetes-related ED visits, although the difference was not statistically significant. The comparison group had increased ED utilization. The intervention group decreased their all-cause total medical costs by $984.87 per member per year (PMPY) compared with a $4547.06 PMPY increase in the comparison group (P <.05). All clinical measures significantly improved (P <.05) in the intervention group.
CONCLUSIONS: A disease management program for high-risk patients with diabetes and CAD was effective in reducing hospital inpatient admission and total costs in a Medicare Advantage population.

Entities:  

Mesh:

Year:  2010        PMID: 20645661

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

Review 1.  Review of strategies to enhance outcomes for patients with type 2 diabetes: payers' perspective.

Authors:  Rhonda Greenapple
Journal:  Am Health Drug Benefits       Date:  2011-09

2.  Using Social Network Analysis to Examine the Effect of Care Management Structure on Chronic Disease Management Communication Within Primary Care.

Authors:  Jodi Summers Holtrop; Sandra Ruland; Stephanie Diaz; Elaine H Morrato; Eric Jones
Journal:  J Gen Intern Med       Date:  2018-01-08       Impact factor: 5.128

3.  Effect of Medicaid disease management programs on emergency admissions and inpatient costs.

Authors:  Matthew S Conti
Journal:  Health Serv Res       Date:  2012-12-26       Impact factor: 3.402

4.  Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.

Authors:  Jose F Figueroa; Daniel M Blumenthal; Yevgeniy Feyman; Austin B Frakt; Alexander Turchin; Gheorghe Doros; Qi Gao; Yang Song; Karen E Joynt Maddox
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

5.  Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.

Authors:  Herwig Ostermann; Victoria Hoess; Michael Mueller
Journal:  BMC Public Health       Date:  2012-06-29       Impact factor: 3.295

6.  Does the Belgian diabetes type 2 care trajectory improve quality of care for diabetes patients?

Authors:  Viviane F A Van Casteren; Nathalie H E Bossuyt; Sarah J S Moreels; Geert Goderis; Katrien Vanthomme; Johan Wens; Etienne W De Clercq
Journal:  Arch Public Health       Date:  2015-07-13

7.  An Insurer-Based Diabetes Educator-Community Partnership: Leveraging Education and Diabetes Support (LEADS).

Authors:  Linda M Siminerio; Karen DePasquale; Patricia Johnson; Margaret Thearle
Journal:  Clin Diabetes       Date:  2015-04

8.  The Association between Medicare Advantage Market Penetration and Diabetes in the United States.

Authors:  Steven W Howard; Stephanie Lazarus Bernell; Jennifer Wilmott; M Faizan Casim; Jing Wang; Lindsey Pearson; Caitlin M Byler; Zidong Zhang
Journal:  Front Public Health       Date:  2015-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.